The FDA's refusal to review Moderna's application to sell a new flu shot is part of a pattern of regulatory U-turns and overruling of FDA staff by Vinay Prasad, head of the agency's vaccine division
ModernaModerna(US:MRNA) WSJ·2026-02-12 10:00

机构人事与决策动态 - 该机构疫苗部门负责人Vinay Prasad否决了来自职业员工的反对意见 [1]

The FDA's refusal to review Moderna's application to sell a new flu shot is part of a pattern of regulatory U-turns and overruling of FDA staff by Vinay Prasad, head of the agency's vaccine division - Reportify